| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

Taylor Morrison Home Corporation (NYSE: TMHC) Surpasses Earnings and Revenue Estimates

Taylor Morrison Home Corporation (NYSE:TMHC) is a leading national land developer and homebuilder, known for its strategic management of inventory, pricing, and sales pace across its communities. Operating in the Zacks Building Products - Home Builders industry, TMHC has consistently outperformed revenue estimates over the past four quarters.

On October 22, 2025, TMHC reported earnings per share (EPS) of $2.01, surpassing the estimated $1.93. This achievement highlights the company's ability to exceed Wall Street expectations. Despite a year-over-year decline in EPS from $2.37, TMHC still delivered a positive surprise of 9.33%, as highlighted by Zacks.

TMHC's revenue for the third quarter of 2025 was $2.1 billion, slightly lower than the previous year's $2.12 billion. However, this figure exceeded the Zacks Consensus Estimate of $2.04 billion, resulting in a positive surprise of 2.76%. This performance underscores the company's resilience in challenging market conditions.

The company's financial health is further supported by a price-to-earnings (P/E) ratio of approximately 6.86, indicating a relatively low valuation compared to its earnings. TMHC's price-to-sales ratio of about 0.73 suggests the market values the company at less than its annual sales, while the enterprise value to sales ratio is approximately 0.97.

TMHC maintains a strong current ratio of approximately 9.43, reflecting its robust ability to cover short-term liabilities with short-term assets. The debt-to-equity ratio of about 0.36 shows a moderate level of debt compared to equity, indicating a balanced financial structure.

Published on: October 22, 2025